nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—CA1—esophageal cancer	0.479	0.569	CbGaD
Diazoxide—CA2—esophageal cancer	0.363	0.431	CbGaD
Diazoxide—GLUL—exocrine gland—esophageal cancer	0.00491	0.083	CbGeAlD
Diazoxide—KCNMA1—exocrine gland—esophageal cancer	0.00456	0.077	CbGeAlD
Diazoxide—GLUL—neck—esophageal cancer	0.00314	0.0531	CbGeAlD
Diazoxide—Chlorothiazide—CA1—esophageal cancer	0.00309	0.569	CrCbGaD
Diazoxide—ATP1A1—exocrine gland—esophageal cancer	0.00293	0.0495	CbGeAlD
Diazoxide—Chlorothiazide—CA2—esophageal cancer	0.00234	0.431	CrCbGaD
Diazoxide—CA2—exocrine gland—esophageal cancer	0.00224	0.0379	CbGeAlD
Diazoxide—GLUL—epithelium—esophageal cancer	0.00214	0.0361	CbGeAlD
Diazoxide—GLUL—bronchus—esophageal cancer	0.0021	0.0356	CbGeAlD
Diazoxide—GLUL—smooth muscle tissue—esophageal cancer	0.00206	0.0348	CbGeAlD
Diazoxide—KCNMA1—epithelium—esophageal cancer	0.00198	0.0335	CbGeAlD
Diazoxide—KCNMA1—smooth muscle tissue—esophageal cancer	0.00191	0.0323	CbGeAlD
Diazoxide—GLUL—trachea—esophageal cancer	0.00189	0.0319	CbGeAlD
Diazoxide—ATP1A1—neck—esophageal cancer	0.00187	0.0316	CbGeAlD
Diazoxide—SLC12A3—lung—esophageal cancer	0.00182	0.0308	CbGeAlD
Diazoxide—ABCC8—smooth muscle tissue—esophageal cancer	0.00178	0.0301	CbGeAlD
Diazoxide—GLUL—digestive system—esophageal cancer	0.00163	0.0275	CbGeAlD
Diazoxide—CA2—neck—esophageal cancer	0.00143	0.0242	CbGeAlD
Diazoxide—GLUL—lung—esophageal cancer	0.00136	0.0229	CbGeAlD
Diazoxide—Herpes virus infection—Capecitabine—esophageal cancer	0.00134	0.0558	CcSEcCtD
Diazoxide—ATP1A1—epithelium—esophageal cancer	0.00127	0.0215	CbGeAlD
Diazoxide—KCNMA1—lung—esophageal cancer	0.00126	0.0213	CbGeAlD
Diazoxide—ATP1A1—bronchus—esophageal cancer	0.00125	0.0212	CbGeAlD
Diazoxide—ATP1A1—smooth muscle tissue—esophageal cancer	0.00123	0.0207	CbGeAlD
Diazoxide—CA1—digestive system—esophageal cancer	0.00115	0.0194	CbGeAlD
Diazoxide—Polyneuropathy—Capecitabine—esophageal cancer	0.00114	0.0475	CcSEcCtD
Diazoxide—ATP1A1—trachea—esophageal cancer	0.00113	0.019	CbGeAlD
Diazoxide—CA2—epithelium—esophageal cancer	0.000976	0.0165	CbGeAlD
Diazoxide—ATP1A1—digestive system—esophageal cancer	0.000969	0.0164	CbGeAlD
Diazoxide—CA2—bronchus—esophageal cancer	0.000961	0.0162	CbGeAlD
Diazoxide—CA1—lung—esophageal cancer	0.000957	0.0162	CbGeAlD
Diazoxide—CA2—smooth muscle tissue—esophageal cancer	0.00094	0.0159	CbGeAlD
Diazoxide—GLUL—lymph node—esophageal cancer	0.000928	0.0157	CbGeAlD
Diazoxide—KCNJ11—lymph node—esophageal cancer	0.000871	0.0147	CbGeAlD
Diazoxide—CA2—trachea—esophageal cancer	0.000863	0.0146	CbGeAlD
Diazoxide—KCNMA1—lymph node—esophageal cancer	0.000861	0.0146	CbGeAlD
Diazoxide—ATP1A1—lung—esophageal cancer	0.000809	0.0137	CbGeAlD
Diazoxide—CA2—digestive system—esophageal cancer	0.000742	0.0126	CbGeAlD
Diazoxide—CA1—lymph node—esophageal cancer	0.000654	0.0111	CbGeAlD
Diazoxide—Hirsutism—Capecitabine—esophageal cancer	0.00064	0.0267	CcSEcCtD
Diazoxide—Ageusia—Cisplatin—esophageal cancer	0.000623	0.0259	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—CRTC1—esophageal cancer	0.000622	0.00898	CbGpPWpGaD
Diazoxide—CA2—lung—esophageal cancer	0.00062	0.0105	CbGeAlD
Diazoxide—KCNMA1—Potassium Channels—GNG7—esophageal cancer	0.000614	0.00887	CbGpPWpGaD
Diazoxide—ABCC8—ABC-family proteins mediated transport—ABCB1—esophageal cancer	0.000574	0.00829	CbGpPWpGaD
Diazoxide—ATP1A1—lymph node—esophageal cancer	0.000553	0.00935	CbGeAlD
Diazoxide—Haemoglobin decreased—Capecitabine—esophageal cancer	0.000541	0.0225	CcSEcCtD
Diazoxide—ABCC8—Regulation of insulin secretion—GNG7—esophageal cancer	0.000534	0.00772	CbGpPWpGaD
Diazoxide—Ileus—Capecitabine—esophageal cancer	0.000526	0.0219	CcSEcCtD
Diazoxide—Pain—Carboplatin—esophageal cancer	0.000525	0.0219	CcSEcCtD
Diazoxide—Azotaemia—Methotrexate—esophageal cancer	0.00052	0.0217	CcSEcCtD
Diazoxide—KCNJ11—Regulation of insulin secretion—GNG7—esophageal cancer	0.000518	0.00748	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—BAX—esophageal cancer	0.000502	0.00725	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000487	0.00704	CbGpPWpGaD
Diazoxide—Body temperature increased—Carboplatin—esophageal cancer	0.000486	0.0202	CcSEcCtD
Diazoxide—Fluid retention—Cisplatin—esophageal cancer	0.000479	0.02	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000476	0.00687	CbGpPWpGaD
Diazoxide—Ageusia—Capecitabine—esophageal cancer	0.000459	0.0191	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000457	0.00659	CbGpPWpGaD
Diazoxide—ABCC8—Potassium Channels—GNG7—esophageal cancer	0.000437	0.00631	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000435	0.00629	CbGpPWpGaD
Diazoxide—CA2—lymph node—esophageal cancer	0.000424	0.00717	CbGeAlD
Diazoxide—KCNJ11—Potassium Channels—GNG7—esophageal cancer	0.000424	0.00612	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—CAPZA1—esophageal cancer	0.000422	0.00609	CbGpPWpGaD
Diazoxide—GLUL—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.000421	0.00608	CbGpPWpGaD
Diazoxide—GLUL—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.000421	0.00608	CbGpPWpGaD
Diazoxide—ABCC8—Integration of energy metabolism—GNG7—esophageal cancer	0.00042	0.00607	CbGpPWpGaD
Diazoxide—KCNJ11—Integration of energy metabolism—GNG7—esophageal cancer	0.000407	0.00588	CbGpPWpGaD
Diazoxide—Lacrimation increased—Capecitabine—esophageal cancer	0.000404	0.0168	CcSEcCtD
Diazoxide—Cataract—Capecitabine—esophageal cancer	0.000391	0.0163	CcSEcCtD
Diazoxide—GLUL—Neuronal System—GNG7—esophageal cancer	0.000373	0.00539	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CASP8—esophageal cancer	0.000356	0.00514	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CREBBP—esophageal cancer	0.000354	0.00512	CbGpPWpGaD
Diazoxide—Fluid retention—Capecitabine—esophageal cancer	0.000353	0.0147	CcSEcCtD
Diazoxide—GLUL—Neuronal System—ALDH2—esophageal cancer	0.00035	0.00505	CbGpPWpGaD
Diazoxide—Hypokalaemia—Cisplatin—esophageal cancer	0.000334	0.0139	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00033	0.0137	CcSEcCtD
Diazoxide—KCNMA1—Platelet homeostasis—NOS2—esophageal cancer	0.000324	0.00467	CbGpPWpGaD
Diazoxide—Pancreatitis—Cisplatin—esophageal cancer	0.000311	0.0129	CcSEcCtD
Diazoxide—Abdominal discomfort—Cisplatin—esophageal cancer	0.000304	0.0126	CcSEcCtD
Diazoxide—Vascular purpura—Capecitabine—esophageal cancer	0.000302	0.0126	CcSEcCtD
Diazoxide—Purpura—Capecitabine—esophageal cancer	0.00028	0.0117	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—ATP1B2—esophageal cancer	0.000279	0.00403	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000271	0.00392	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000271	0.00392	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—GHRL—esophageal cancer	0.000271	0.00391	CbGpPWpGaD
Diazoxide—Diplopia—Capecitabine—esophageal cancer	0.00027	0.0112	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—GNG7—esophageal cancer	0.000268	0.00387	CbGpPWpGaD
Diazoxide—KCNMA1—Platelet homeostasis—NOS3—esophageal cancer	0.00026	0.00376	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000255	0.00368	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000255	0.00368	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—DOCK2—esophageal cancer	0.000253	0.00365	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—ALDH2—esophageal cancer	0.000251	0.00363	CbGpPWpGaD
Diazoxide—Hypokalaemia—Capecitabine—esophageal cancer	0.000246	0.0102	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000243	0.0101	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000242	0.00349	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000242	0.00349	CbGpPWpGaD
Diazoxide—Lymphadenopathy—Methotrexate—esophageal cancer	0.000236	0.00981	CcSEcCtD
Diazoxide—Flushing—Cisplatin—esophageal cancer	0.000235	0.0098	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000231	0.00333	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000231	0.00333	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000229	0.00331	CbGpPWpGaD
Diazoxide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000224	0.00932	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000221	0.00319	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000221	0.00319	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000221	0.00319	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000221	0.00319	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PFN1—esophageal cancer	0.000218	0.00315	CbGpPWpGaD
Diazoxide—Weight increased—Capecitabine—esophageal cancer	0.000213	0.00885	CcSEcCtD
Diazoxide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000211	0.00877	CcSEcCtD
Diazoxide—Vision blurred—Cisplatin—esophageal cancer	0.000208	0.00866	CcSEcCtD
Diazoxide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000205	0.00853	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000201	0.0029	CbGpPWpGaD
Diazoxide—Malaise—Cisplatin—esophageal cancer	0.000199	0.00829	CcSEcCtD
Diazoxide—Haematuria—Capecitabine—esophageal cancer	0.000199	0.00827	CcSEcCtD
Diazoxide—Leukopenia—Cisplatin—esophageal cancer	0.000198	0.00823	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—BCL2—esophageal cancer	0.000197	0.00285	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC52A3—esophageal cancer	0.000197	0.00285	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—BLVRB—esophageal cancer	0.000197	0.00285	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—GNG7—esophageal cancer	0.000191	0.00275	CbGpPWpGaD
Diazoxide—Haemoglobin—Capecitabine—esophageal cancer	0.000188	0.00782	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—esophageal cancer	0.000188	0.00271	CbGpPWpGaD
Diazoxide—Anxiety—Cisplatin—esophageal cancer	0.000187	0.0078	CcSEcCtD
Diazoxide—Haemorrhage—Capecitabine—esophageal cancer	0.000187	0.00778	CcSEcCtD
Diazoxide—Discomfort—Cisplatin—esophageal cancer	0.000186	0.00773	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—GNG7—esophageal cancer	0.000185	0.00267	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000183	0.00264	CbGpPWpGaD
Diazoxide—Oedema—Cisplatin—esophageal cancer	0.00018	0.0075	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—ALDH2—esophageal cancer	0.000179	0.00258	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—CFL1—esophageal cancer	0.000177	0.00255	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000176	0.00734	CcSEcCtD
Diazoxide—Tachycardia—Cisplatin—esophageal cancer	0.000176	0.00732	CcSEcCtD
Diazoxide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000174	0.00725	CcSEcCtD
Diazoxide—Flushing—Capecitabine—esophageal cancer	0.000173	0.00722	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—ALDH2—esophageal cancer	0.000173	0.0025	CbGpPWpGaD
Diazoxide—Eosinophilia—Methotrexate—esophageal cancer	0.000172	0.00717	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000172	0.00248	CbGpPWpGaD
Diazoxide—Anorexia—Cisplatin—esophageal cancer	0.000172	0.00715	CcSEcCtD
Diazoxide—Pancreatitis—Methotrexate—esophageal cancer	0.00017	0.0071	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—esophageal cancer	0.00017	0.00245	CbGpPWpGaD
Diazoxide—Hypotension—Cisplatin—esophageal cancer	0.000168	0.00701	CcSEcCtD
Diazoxide—GLUL—Metabolism—CA1—esophageal cancer	0.000168	0.00242	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC10A2—esophageal cancer	0.000168	0.00242	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000168	0.00242	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000168	0.00242	CbGpPWpGaD
Diazoxide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000167	0.00694	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—GNG7—esophageal cancer	0.000167	0.00241	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000164	0.00237	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000163	0.00236	CbGpPWpGaD
Diazoxide—Paraesthesia—Cisplatin—esophageal cancer	0.000162	0.00673	CcSEcCtD
Diazoxide—Decreased appetite—Cisplatin—esophageal cancer	0.000157	0.00652	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—EP300—esophageal cancer	0.000156	0.00225	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000156	0.00225	CbGpPWpGaD
Diazoxide—Pain—Cisplatin—esophageal cancer	0.000154	0.00641	CcSEcCtD
Diazoxide—GLUL—Metabolism—CA2—esophageal cancer	0.000153	0.00221	CbGpPWpGaD
Diazoxide—Vision blurred—Capecitabine—esophageal cancer	0.000153	0.00638	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000152	0.0022	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000152	0.0022	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—NOS2—esophageal cancer	0.000152	0.00219	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000151	0.00629	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000149	0.00215	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000149	0.00215	CbGpPWpGaD
Diazoxide—Sweating—Methotrexate—esophageal cancer	0.000149	0.00619	CcSEcCtD
Diazoxide—Feeling abnormal—Cisplatin—esophageal cancer	0.000148	0.00618	CcSEcCtD
Diazoxide—Haematuria—Methotrexate—esophageal cancer	0.000148	0.00615	CcSEcCtD
Diazoxide—Malaise—Capecitabine—esophageal cancer	0.000147	0.00611	CcSEcCtD
Diazoxide—Leukopenia—Capecitabine—esophageal cancer	0.000146	0.00606	CcSEcCtD
Diazoxide—Palpitations—Capecitabine—esophageal cancer	0.000144	0.00599	CcSEcCtD
Diazoxide—GLUL—Metabolism—PLCE1—esophageal cancer	0.000143	0.00206	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ADH7—esophageal cancer	0.000143	0.00206	CbGpPWpGaD
Diazoxide—Body temperature increased—Cisplatin—esophageal cancer	0.000142	0.00593	CcSEcCtD
Diazoxide—Hypertension—Capecitabine—esophageal cancer	0.00014	0.00585	CcSEcCtD
Diazoxide—Haemoglobin—Methotrexate—esophageal cancer	0.00014	0.00582	CcSEcCtD
Diazoxide—Haemorrhage—Methotrexate—esophageal cancer	0.000139	0.00579	CcSEcCtD
Diazoxide—Chest pain—Capecitabine—esophageal cancer	0.000139	0.00577	CcSEcCtD
Diazoxide—Anxiety—Capecitabine—esophageal cancer	0.000138	0.00575	CcSEcCtD
Diazoxide—Discomfort—Capecitabine—esophageal cancer	0.000137	0.0057	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—MYC—esophageal cancer	0.000136	0.00196	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HSPA5—esophageal cancer	0.000136	0.00196	CbGpPWpGaD
Diazoxide—Oedema—Capecitabine—esophageal cancer	0.000133	0.00553	CcSEcCtD
Diazoxide—Hypersensitivity—Cisplatin—esophageal cancer	0.000133	0.00553	CcSEcCtD
Diazoxide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00013	0.00541	CcSEcCtD
Diazoxide—Tachycardia—Capecitabine—esophageal cancer	0.00013	0.0054	CcSEcCtD
Diazoxide—Asthenia—Cisplatin—esophageal cancer	0.000129	0.00538	CcSEcCtD
Diazoxide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000128	0.00534	CcSEcCtD
Diazoxide—Anorexia—Capecitabine—esophageal cancer	0.000127	0.00527	CcSEcCtD
Diazoxide—GLUL—Metabolism—ADH1B—esophageal cancer	0.000125	0.00181	CbGpPWpGaD
Diazoxide—Hypotension—Capecitabine—esophageal cancer	0.000124	0.00517	CcSEcCtD
Diazoxide—CA2—Metabolism—BLVRB—esophageal cancer	0.000124	0.00179	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC52A3—esophageal cancer	0.000124	0.00179	CbGpPWpGaD
Diazoxide—Diarrhoea—Cisplatin—esophageal cancer	0.000123	0.00513	CcSEcCtD
Diazoxide—Insomnia—Capecitabine—esophageal cancer	0.00012	0.005	CcSEcCtD
Diazoxide—GLUL—Metabolism—TYMP—esophageal cancer	0.000119	0.00173	CbGpPWpGaD
Diazoxide—Paraesthesia—Capecitabine—esophageal cancer	0.000119	0.00496	CcSEcCtD
Diazoxide—CA1—Metabolism—BLVRB—esophageal cancer	0.000119	0.00171	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC52A3—esophageal cancer	0.000119	0.00171	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP26A1—esophageal cancer	0.000116	0.00168	CbGpPWpGaD
Diazoxide—Decreased appetite—Capecitabine—esophageal cancer	0.000115	0.00481	CcSEcCtD
Diazoxide—Vomiting—Cisplatin—esophageal cancer	0.000115	0.00477	CcSEcCtD
Diazoxide—Vision blurred—Methotrexate—esophageal cancer	0.000114	0.00475	CcSEcCtD
Diazoxide—Rash—Cisplatin—esophageal cancer	0.000114	0.00473	CcSEcCtD
Diazoxide—Pain—Capecitabine—esophageal cancer	0.000114	0.00473	CcSEcCtD
Diazoxide—Dermatitis—Cisplatin—esophageal cancer	0.000113	0.00472	CcSEcCtD
Diazoxide—GLUL—Metabolism—ALOX15—esophageal cancer	0.000113	0.00164	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000113	0.00163	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000112	0.00468	CcSEcCtD
Diazoxide—Feeling abnormal—Capecitabine—esophageal cancer	0.000109	0.00456	CcSEcCtD
Diazoxide—Malaise—Methotrexate—esophageal cancer	0.000109	0.00455	CcSEcCtD
Diazoxide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000109	0.00452	CcSEcCtD
Diazoxide—Leukopenia—Methotrexate—esophageal cancer	0.000108	0.00451	CcSEcCtD
Diazoxide—GLUL—Metabolism—TPI1—esophageal cancer	0.000108	0.00156	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTO1—esophageal cancer	0.000108	0.00156	CbGpPWpGaD
Diazoxide—Nausea—Cisplatin—esophageal cancer	0.000107	0.00446	CcSEcCtD
Diazoxide—CA2—Metabolism—CA1—esophageal cancer	0.000105	0.00152	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC10A2—esophageal cancer	0.000105	0.00152	CbGpPWpGaD
Diazoxide—Abdominal pain—Capecitabine—esophageal cancer	0.000105	0.00437	CcSEcCtD
Diazoxide—Body temperature increased—Capecitabine—esophageal cancer	0.000105	0.00437	CcSEcCtD
Diazoxide—GLUL—Metabolism—ALDOB—esophageal cancer	0.000104	0.0015	CbGpPWpGaD
Diazoxide—Chest pain—Methotrexate—esophageal cancer	0.000103	0.00429	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000103	0.00148	CbGpPWpGaD
Diazoxide—Discomfort—Methotrexate—esophageal cancer	0.000102	0.00424	CcSEcCtD
Diazoxide—ABCC8—Metabolism—SLC52A3—esophageal cancer	0.000101	0.00146	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—BLVRB—esophageal cancer	0.000101	0.00146	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC10A2—esophageal cancer	0.000101	0.00146	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—ABL1—esophageal cancer	0.000101	0.00145	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GAPDH—esophageal cancer	9.97e-05	0.00144	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CRABP1—esophageal cancer	9.88e-05	0.00143	CbGpPWpGaD
Diazoxide—Hypersensitivity—Capecitabine—esophageal cancer	9.78e-05	0.00407	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—BLVRB—esophageal cancer	9.77e-05	0.00141	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC52A3—esophageal cancer	9.77e-05	0.00141	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Methotrexate—esophageal cancer	9.68e-05	0.00403	CcSEcCtD
Diazoxide—Hyperhidrosis—Methotrexate—esophageal cancer	9.56e-05	0.00398	CcSEcCtD
Diazoxide—Asthenia—Capecitabine—esophageal cancer	9.53e-05	0.00397	CcSEcCtD
Diazoxide—Anorexia—Methotrexate—esophageal cancer	9.42e-05	0.00392	CcSEcCtD
Diazoxide—GLUL—Metabolism—GNG7—esophageal cancer	9.4e-05	0.00136	CbGpPWpGaD
Diazoxide—Pruritus—Capecitabine—esophageal cancer	9.4e-05	0.00391	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EP300—esophageal cancer	9.28e-05	0.00134	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.27e-05	0.00134	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.27e-05	0.00134	CbGpPWpGaD
Diazoxide—Hypotension—Methotrexate—esophageal cancer	9.24e-05	0.00385	CcSEcCtD
Diazoxide—CA1—Metabolism—CA2—esophageal cancer	9.22e-05	0.00133	CbGpPWpGaD
Diazoxide—Diarrhoea—Capecitabine—esophageal cancer	9.09e-05	0.00378	CcSEcCtD
Diazoxide—Insomnia—Methotrexate—esophageal cancer	8.94e-05	0.00372	CcSEcCtD
Diazoxide—CA2—Metabolism—ADH7—esophageal cancer	8.94e-05	0.00129	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PLCE1—esophageal cancer	8.94e-05	0.00129	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.9e-05	0.00128	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.9e-05	0.00128	CbGpPWpGaD
Diazoxide—Paraesthesia—Methotrexate—esophageal cancer	8.88e-05	0.0037	CcSEcCtD
Diazoxide—GLUL—Metabolism—ALDH2—esophageal cancer	8.81e-05	0.00127	CbGpPWpGaD
Diazoxide—Dizziness—Capecitabine—esophageal cancer	8.78e-05	0.00366	CcSEcCtD
Diazoxide—Decreased appetite—Methotrexate—esophageal cancer	8.59e-05	0.00358	CcSEcCtD
Diazoxide—ABCC8—Metabolism—SLC10A2—esophageal cancer	8.57e-05	0.00124	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ADH7—esophageal cancer	8.57e-05	0.00124	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CA1—esophageal cancer	8.57e-05	0.00124	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PLCE1—esophageal cancer	8.57e-05	0.00124	CbGpPWpGaD
Diazoxide—Pain—Methotrexate—esophageal cancer	8.45e-05	0.00352	CcSEcCtD
Diazoxide—Vomiting—Capecitabine—esophageal cancer	8.44e-05	0.00352	CcSEcCtD
Diazoxide—GLUL—Metabolism—GSTT1—esophageal cancer	8.38e-05	0.00121	CbGpPWpGaD
Diazoxide—Rash—Capecitabine—esophageal cancer	8.37e-05	0.00349	CcSEcCtD
Diazoxide—Dermatitis—Capecitabine—esophageal cancer	8.37e-05	0.00348	CcSEcCtD
Diazoxide—Headache—Capecitabine—esophageal cancer	8.32e-05	0.00346	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—CA1—esophageal cancer	8.31e-05	0.0012	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC10A2—esophageal cancer	8.31e-05	0.0012	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP2A6—esophageal cancer	8.28e-05	0.0012	CbGpPWpGaD
Diazoxide—Feeling abnormal—Methotrexate—esophageal cancer	8.15e-05	0.00339	CcSEcCtD
Diazoxide—Gastrointestinal pain—Methotrexate—esophageal cancer	8.08e-05	0.00337	CcSEcCtD
Diazoxide—Nausea—Capecitabine—esophageal cancer	7.89e-05	0.00328	CcSEcCtD
Diazoxide—GLUL—Metabolism—PTGS1—esophageal cancer	7.85e-05	0.00113	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ENO1—esophageal cancer	7.85e-05	0.00113	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ADH1B—esophageal cancer	7.84e-05	0.00113	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CA2—esophageal cancer	7.84e-05	0.00113	CbGpPWpGaD
Diazoxide—Body temperature increased—Methotrexate—esophageal cancer	7.81e-05	0.00325	CcSEcCtD
Diazoxide—Abdominal pain—Methotrexate—esophageal cancer	7.81e-05	0.00325	CcSEcCtD
Diazoxide—GLUL—Metabolism—PSME2—esophageal cancer	7.74e-05	0.00112	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PSME1—esophageal cancer	7.74e-05	0.00112	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CA2—esophageal cancer	7.6e-05	0.0011	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ADH1B—esophageal cancer	7.51e-05	0.00109	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMP—esophageal cancer	7.49e-05	0.00108	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ADH7—esophageal cancer	7.29e-05	0.00105	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PLCE1—esophageal cancer	7.29e-05	0.00105	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP26A1—esophageal cancer	7.29e-05	0.00105	CbGpPWpGaD
Diazoxide—Hypersensitivity—Methotrexate—esophageal cancer	7.28e-05	0.00303	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—NOS2—esophageal cancer	7.25e-05	0.00105	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMP—esophageal cancer	7.18e-05	0.00104	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALOX15—esophageal cancer	7.1e-05	0.00103	CbGpPWpGaD
Diazoxide—Asthenia—Methotrexate—esophageal cancer	7.09e-05	0.00295	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—ADH7—esophageal cancer	7.07e-05	0.00102	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PLCE1—esophageal cancer	7.07e-05	0.00102	CbGpPWpGaD
Diazoxide—Pruritus—Methotrexate—esophageal cancer	6.99e-05	0.00291	CcSEcCtD
Diazoxide—CA1—Metabolism—CYP26A1—esophageal cancer	6.99e-05	0.00101	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ALOX15—esophageal cancer	6.81e-05	0.000983	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTO1—esophageal cancer	6.77e-05	0.000978	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TPI1—esophageal cancer	6.77e-05	0.000978	CbGpPWpGaD
Diazoxide—Diarrhoea—Methotrexate—esophageal cancer	6.76e-05	0.00282	CcSEcCtD
Diazoxide—GLUL—Metabolism—CYP1B1—esophageal cancer	6.68e-05	0.000964	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—esophageal cancer	6.64e-05	0.000959	CbGpPWpGaD
Diazoxide—Dizziness—Methotrexate—esophageal cancer	6.54e-05	0.00272	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—CREBBP—esophageal cancer	6.51e-05	0.00094	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALDOB—esophageal cancer	6.49e-05	0.000938	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TPI1—esophageal cancer	6.49e-05	0.000938	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTO1—esophageal cancer	6.49e-05	0.000938	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ADH1B—esophageal cancer	6.39e-05	0.000923	CbGpPWpGaD
Diazoxide—Vomiting—Methotrexate—esophageal cancer	6.29e-05	0.00262	CcSEcCtD
Diazoxide—GLUL—Metabolism—CYP19A1—esophageal cancer	6.28e-05	0.000906	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GAPDH—esophageal cancer	6.25e-05	0.000903	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.25e-05	0.000902	CbGpPWpGaD
Diazoxide—Rash—Methotrexate—esophageal cancer	6.23e-05	0.0026	CcSEcCtD
Diazoxide—Dermatitis—Methotrexate—esophageal cancer	6.23e-05	0.00259	CcSEcCtD
Diazoxide—CA1—Metabolism—ALDOB—esophageal cancer	6.23e-05	0.000899	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CRABP1—esophageal cancer	6.2e-05	0.000895	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ADH1B—esophageal cancer	6.2e-05	0.000895	CbGpPWpGaD
Diazoxide—Headache—Methotrexate—esophageal cancer	6.19e-05	0.00258	CcSEcCtD
Diazoxide—ABCC8—Metabolism—TYMP—esophageal cancer	6.11e-05	0.000882	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6e-05	0.000866	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GAPDH—esophageal cancer	5.99e-05	0.000866	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.95e-05	0.000859	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.95e-05	0.000859	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CRABP1—esophageal cancer	5.94e-05	0.000858	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP26A1—esophageal cancer	5.94e-05	0.000858	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMP—esophageal cancer	5.92e-05	0.000855	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GNG7—esophageal cancer	5.89e-05	0.000851	CbGpPWpGaD
Diazoxide—Nausea—Methotrexate—esophageal cancer	5.87e-05	0.00244	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—NOS3—esophageal cancer	5.83e-05	0.000842	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALOX15—esophageal cancer	5.79e-05	0.000836	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP26A1—esophageal cancer	5.76e-05	0.000832	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—HMOX1—esophageal cancer	5.73e-05	0.000827	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GNG7—esophageal cancer	5.65e-05	0.000816	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALOX15—esophageal cancer	5.61e-05	0.000811	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALDH2—esophageal cancer	5.52e-05	0.000797	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TPI1—esophageal cancer	5.52e-05	0.000797	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTO1—esophageal cancer	5.52e-05	0.000797	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ABCB1—esophageal cancer	5.5e-05	0.000794	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TPI1—esophageal cancer	5.36e-05	0.000773	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTO1—esophageal cancer	5.36e-05	0.000773	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALDOB—esophageal cancer	5.29e-05	0.000765	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ALDH2—esophageal cancer	5.29e-05	0.000765	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTT1—esophageal cancer	5.25e-05	0.000759	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP2A6—esophageal cancer	5.19e-05	0.00075	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALDOB—esophageal cancer	5.13e-05	0.000741	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GAPDH—esophageal cancer	5.1e-05	0.000736	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CRABP1—esophageal cancer	5.05e-05	0.000729	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTT1—esophageal cancer	5.04e-05	0.000727	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP2A6—esophageal cancer	4.98e-05	0.000719	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GAPDH—esophageal cancer	4.94e-05	0.000714	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS1—esophageal cancer	4.92e-05	0.000711	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ENO1—esophageal cancer	4.92e-05	0.000711	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CRABP1—esophageal cancer	4.9e-05	0.000707	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PSME2—esophageal cancer	4.85e-05	0.0007	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PSME1—esophageal cancer	4.85e-05	0.0007	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GNG7—esophageal cancer	4.8e-05	0.000694	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ENO1—esophageal cancer	4.72e-05	0.000681	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS1—esophageal cancer	4.72e-05	0.000681	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GNG7—esophageal cancer	4.66e-05	0.000673	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PSME2—esophageal cancer	4.65e-05	0.000671	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PSME1—esophageal cancer	4.65e-05	0.000671	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALDH2—esophageal cancer	4.5e-05	0.00065	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—EP300—esophageal cancer	4.43e-05	0.00064	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALDH2—esophageal cancer	4.37e-05	0.00063	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTT1—esophageal cancer	4.28e-05	0.000618	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP2A6—esophageal cancer	4.23e-05	0.000611	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP1B1—esophageal cancer	4.19e-05	0.000604	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTT1—esophageal cancer	4.15e-05	0.0006	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP2A6—esophageal cancer	4.1e-05	0.000593	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS1—esophageal cancer	4.01e-05	0.000579	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP1B1—esophageal cancer	4.01e-05	0.000579	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ENO1—esophageal cancer	4.01e-05	0.000579	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.01e-05	0.000579	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PSME2—esophageal cancer	3.95e-05	0.000571	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PSME1—esophageal cancer	3.95e-05	0.000571	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP19A1—esophageal cancer	3.93e-05	0.000568	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS1—esophageal cancer	3.89e-05	0.000562	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ENO1—esophageal cancer	3.89e-05	0.000562	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PSME2—esophageal cancer	3.83e-05	0.000554	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PSME1—esophageal cancer	3.83e-05	0.000554	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP19A1—esophageal cancer	3.77e-05	0.000545	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CREBBP—esophageal cancer	3.67e-05	0.000531	CbGpPWpGaD
Diazoxide—CA2—Metabolism—HMOX1—esophageal cancer	3.59e-05	0.000519	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ABCB1—esophageal cancer	3.45e-05	0.000498	CbGpPWpGaD
Diazoxide—CA1—Metabolism—HMOX1—esophageal cancer	3.44e-05	0.000497	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP1B1—esophageal cancer	3.41e-05	0.000493	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP1B1—esophageal cancer	3.31e-05	0.000478	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ABCB1—esophageal cancer	3.3e-05	0.000477	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NOS3—esophageal cancer	3.29e-05	0.000475	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—esophageal cancer	3.28e-05	0.000474	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP19A1—esophageal cancer	3.21e-05	0.000463	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—esophageal cancer	3.17e-05	0.000458	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP19A1—esophageal cancer	3.11e-05	0.000449	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—esophageal cancer	3.01e-05	0.000435	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—HMOX1—esophageal cancer	2.93e-05	0.000423	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—HMOX1—esophageal cancer	2.84e-05	0.00041	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ABCB1—esophageal cancer	2.81e-05	0.000406	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ABCB1—esophageal cancer	2.72e-05	0.000393	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—EP300—esophageal cancer	2.5e-05	0.000361	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CREBBP—esophageal cancer	2.3e-05	0.000333	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CREBBP—esophageal cancer	2.21e-05	0.000319	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NOS3—esophageal cancer	2.06e-05	0.000298	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NOS3—esophageal cancer	1.98e-05	0.000286	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—esophageal cancer	1.89e-05	0.000272	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CREBBP—esophageal cancer	1.88e-05	0.000271	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—esophageal cancer	1.85e-05	0.000267	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CREBBP—esophageal cancer	1.82e-05	0.000263	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—esophageal cancer	1.81e-05	0.000261	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NOS3—esophageal cancer	1.68e-05	0.000243	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NOS3—esophageal cancer	1.63e-05	0.000235	CbGpPWpGaD
Diazoxide—CA2—Metabolism—EP300—esophageal cancer	1.57e-05	0.000227	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—esophageal cancer	1.54e-05	0.000222	CbGpPWpGaD
Diazoxide—CA1—Metabolism—EP300—esophageal cancer	1.5e-05	0.000217	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—esophageal cancer	1.49e-05	0.000215	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—EP300—esophageal cancer	1.28e-05	0.000185	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—EP300—esophageal cancer	1.24e-05	0.000179	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—esophageal cancer	1.16e-05	0.000168	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—esophageal cancer	1.11e-05	0.000161	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—esophageal cancer	9.46e-06	0.000137	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—esophageal cancer	9.17e-06	0.000132	CbGpPWpGaD
